Influence of Sildenafil on Genital Engorgement in Women with Female Sexual Arousal Disorder

被引:13
|
作者
Leddy, Laura S.
Yang, Claire C. [1 ]
Stuckey, Bronwyn G. [2 ]
Sudworth, Maria [3 ]
Haughie, Scott [4 ]
Sultana, Stefan [4 ]
Maravilla, Kenneth R.
机构
[1] Univ Washington, Dept Urol, Seattle, WA 98195 USA
[2] Keogh Inst Med Res, Nedlands, WA, Australia
[3] Pfizer Inc, Sandwich, Kent, England
[4] Pfizer Inc, New York, NY USA
来源
JOURNAL OF SEXUAL MEDICINE | 2012年 / 9卷 / 10期
关键词
Female Sexual Arousal Disorder; Genital Engorgement; Sildenafil; Magnetic Resonance Imaging; HUMAN CLITORIS; DOUBLE-BLIND; DYSFUNCTION; EXPRESSION; CITRATE; EFFICACY; SAFETY;
D O I
10.1111/j.1743-6109.2012.02796.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. We previously described dynamic, noncontrast magnetic resonance imaging (MRI) of the female genitalia as a reproducible, nonintrusive, objective means of quantifying sexual arousal response in women without sexual difficulties. These studies showed an increase in clitoral engorgement ranging from 50 to 300% in healthy women during sexual arousal. Aim. This study sought to evaluate the genital arousal response in women with female sexual arousal disorder (FSAD) after administration of sildenafil and placebo. We performed a multicenter, double-blind, placebo-controlled, cross-over study to assess the clitoral engorgement response using dynamic MRI in women with FSAD after administering sildenafil and placebo followed by audiovisual sexual stimulation (AVSS). Methods. Nineteen premenopausal women with FSAD underwent two MRI sessions. Subjects were randomized to receive either (i) sildenafil 100 mg during the first session followed by placebo during the second session, or (ii) placebo followed by sildenafil. During each session, baseline MR images were obtained while subjects viewed a neutral video. Subjects then ingested sildenafil or placebo. After 30 minutes, a series of MRIs were obtained at 3-minute intervals for 10 time points while subjects viewed AVSS. Main Outcome Measures. A positive sexual arousal response was achieved if clitoral volume increased =50% from baseline. Results. Thirteen of 19 (68%) subjects achieved a =50% increase in clitoral engorgement from baseline when administered sildenafil or placebo 30 minutes after dose administration. At 60 minutes after administration, 17/19 (89%) subjects receiving sildenafil and 16/19 (84%) subjects receiving placebo had responded (P value 0.3173). Conclusions. Sildenafil did not augment the genital response in women with FSAD. Secondarily, a majority of women in this study did not have impaired clitoral engorgement as measured by MRI, suggesting that FSAD is not predominantly a disorder of genital engorgement. Leddy LS, Yang CC, Stuckey BG, Sudworth M, Haughie S, Sultana S, and Maravilla KR. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder. J Sex Med **;**:****.
引用
收藏
页码:2693 / 2697
页数:5
相关论文
共 50 条
  • [1] INFLUENCE OF PDE5 INHIBITOR ON GENITAL ENGORGEMENT IN WOMEN WITH FEMALE SEXUAL AROUSAL DISORDER
    Leddy, L.
    Yang, C.
    Stuckey, B.
    Sudworth, M.
    Haughie, S.
    Sultana, S.
    Maravilla, K.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 63 - 63
  • [2] Sildenafil is not effective in postmenopausal women with acquired genital sexual arousal disorder
    不详
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7438):
  • [3] Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder
    Basson, R
    McInnes, R
    Smith, MD
    Hodgson, G
    Koppiker, N
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (04): : 367 - 377
  • [4] Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder
    Berman, JR
    Berman, LA
    Lin, H
    Flaherty, E
    Lahey, N
    Goldstein, I
    Cantey-Kiser, J
    [J]. JOURNAL OF SEX & MARITAL THERAPY, 2001, 27 (05) : 411 - 420
  • [5] Sildenafil citrate for female sexual arousal disorder: a future possibility?
    Schoen, Corina
    Bachmann, Gloria
    [J]. NATURE REVIEWS UROLOGY, 2009, 6 (04) : 216 - 222
  • [6] Sildenafil citrate for female sexual arousal disorder: a future possibility?
    Corina Schoen
    Gloria Bachmann
    [J]. Nature Reviews Urology, 2009, 6 : 216 - 222
  • [7] FSFI Scores of Women with Persistent Genital Arousal Disorder Compared with Published Scores of Women with Female Sexual Arousal Disorder and Healthy Controls
    Leiblum, Sandra R.
    Seehuus, Martin
    [J]. JOURNAL OF SEXUAL MEDICINE, 2009, 6 (02): : 469 - 473
  • [8] Establishment of Rat Model of Female Genital Sexual Arousal Disorder
    Li, Guangyong
    Yu, Puguang
    Hu, Yanan
    Hu, Zhenxing
    Li, Jian
    Zhan, Xuekang
    Su, Yashan
    Yu, Chen
    Wen, Jing
    Liu, Hetao
    He, Rui
    [J]. SEXUAL MEDICINE, 2022, 10 (04)
  • [9] Female Sexual Arousal Disorder Sildenafil Cream as Potential Treatment in Development
    Pinkerton, JoAnn V.
    [J]. OBSTETRICS AND GYNECOLOGY, 2024, 144 (02): : 142 - 143
  • [10] A prospective duplex Doppler ultrasonographic study in women with sexual arousal disorder to objectively assess genital engorgement induced by EROS therapy
    Munarriz, R
    Maitland, S
    Garcia, SP
    Talakoub, L
    Goldstein, I
    [J]. JOURNAL OF SEX & MARITAL THERAPY, 2003, 29 (01) : 85 - 94